EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessment of the Therapeutic Potential of Enhancer of Zeste Homolog 2 Inhibition in a Murine Model of Bronchiolitis Obliterans Syndrome

Kyoto Matsudo, Shinkichi Takamori, Tomoyoshi Takenaka, Mototsugu Shimokawa, Asato Hashinokuchi, Taichi Nagano, Fumihiko Kinoshita, Takaki Akamine, Mikihiro Kohno, Gouji Toyokawa, Tomoharu Yoshizumi

Transplant International · 2024

DOI: 10.3389/ti.2024.13227 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant International, 2024. Verfasst von Kyoto Matsudo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Hauptthemen laut MEDLINE: Bronchiolitis Obliterans, Enhancer of Zeste Homolog 2 Protein, Disease Models, Animal, Adenosine. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bronchiolitis obliterans syndrome (BOS) is a chronic complication following lung transplantation that limits the long-term survival. Although the enhancer of zeste homolog 2 (EZH2) is involved in post-transplantation rejection, its involvement in BOS pathogenesis remains unclear. We aimed to investigate the therapeutic potential of EZH2 inhibition in BOS. 3-deazaneplanocin A (DZNep) was administered intraperitoneally to heterotopic tracheal transplant recipient model mice. Tracheal allografts were obtained on days 7, 14, 21, and 28 after transplantation. The obstruction ratios of the DZNep and control groups on days 7, 14, 21, and 28 were 15.1% ± 0.8% vs. 20.4% ± 3.6% ( p = 0.996), 16.9% ± 2.1% vs. 67.7% ± 11.5% ( p < 0.001), 47.8% ± 7.8% vs. 92.2% ± 5.4% ( p < 0.001), and 60.0% ± 9.6% vs. 95.0% ± 2.3% ( p < 0.001), respectively. The levels of interleukin (IL)-6 and interferon-γ on day 7 and those of IL-2, tumor necrosis factor, and IL-17A on days 14, 21, and 28 were significantly reduced following DZNep treatment. DZNep significantly decreased the number of infiltrating T-cells on day 14. In conclusion, DZNep-mediated EZH2 inhibition suppressed the inflammatory reactions driven by pro-inflammatory cytokines and T cell infiltration, thereby alleviating BOS symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bronchiolitis ObliteransEnhancer of Zeste Homolog 2 ProteinDisease Models, AnimalAdenosineMice, Inbred BALB CAnimalsMiceMaleMice, Inbred C57BLLung TransplantationInterleukin-17CytokinesBronchiolitis Obliterans Syndrome

Stichwörter der Autor:innen

3-deazaneplanocin Abronchiolitis obliterans syndromechronic lung allograft dysfunctionenhancer of zeste homolog 2lung transplantation

Substanzen

Enhancer of Zeste Homolog 2 Protein3-deazaneplanocinAdenosineEzh2 protein, mouseInterleukin-17Cytokines

Autor:innen und Institutionen

  • Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Thoracic and Breast Surgery, Oita University Faculty of Medicine, Oita, Japan.
  • Department of Biostatistics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
  • Department of Thoracic Surgery, Clinical Research Institute, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan.

Zitieren

APA

Matsudo, K., Takamori, S., Takenaka, T., Shimokawa, M., Hashinokuchi, A., Nagano, T., Kinoshita, F., Akamine, T., Kohno, M., Toyokawa, G., & Yoshizumi, T. (2024). Assessment of the Therapeutic Potential of Enhancer of Zeste Homolog 2 Inhibition in a Murine Model of Bronchiolitis Obliterans Syndrome. Transplant International. https://doi.org/10.3389/ti.2024.13227

Vancouver

Matsudo K, Takamori S, Takenaka T, Shimokawa M, Hashinokuchi A, Nagano T, et al. Assessment of the Therapeutic Potential of Enhancer of Zeste Homolog 2 Inhibition in a Murine Model of Bronchiolitis Obliterans Syndrome. Transplant International. 2024. doi:10.3389/ti.2024.13227

BibTeX
@article{Matsudo2024,
  author = {Matsudo, Kyoto and Takamori, Shinkichi and Takenaka, Tomoyoshi and Shimokawa, Mototsugu and Hashinokuchi, Asato and Nagano, Taichi and Kinoshita, Fumihiko and Akamine, Takaki and Kohno, Mikihiro and Toyokawa, Gouji and Yoshizumi, Tomoharu},
  title = {Assessment of the Therapeutic Potential of Enhancer of Zeste Homolog 2 Inhibition in a Murine Model of Bronchiolitis Obliterans Syndrome},
  journal = {Transplant International},
  year = {2024},
  doi = {10.3389/ti.2024.13227}
}
Kostenlos starten →